Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Robinson

Showing results (51-60 of 111) with videos related to

Pageof 12
Sort By:
The Journal of Pathology. Clinical Research|February 26, 2021
Recommendations for cellular and molecular pathology input into clinical trials: a systematic review and meta-aggregationShujing Jane Lim, Kurinchi Gurusamy, Daniel O'Connor, et al.
Oral Oncology|November 10, 2018
Concurrent HPV-related oropharyngeal carcinoma in four couplesHans Prakash Sathasivam, Ramya Bhatia, Paula Bradley, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 20, 2016
Changes in Epidermal Growth Factor Receptor Gene Copy Number during Oral CarcinogenesisTimothy Bates, Matthew Kennedy, Ameena Diajil, et al.
Oral Oncology|May 31, 2022
Transoral robotic surgery and neck dissection alone for head and neck squamous cell carcinoma: Influence of resection margins on oncological outcomesLaura Warner, James T O'Hara, Daniel J Lin, et al.
The Journal of Pathology. Clinical Research|May 31, 2022
Assessment of clinical trial protocols for pathology content using the SPIRIT-Path guidelines highlights areas for improvementPeter Robinson, Chris M Bacon, Shujing J Lim, et al.
Scientific Reports|July 10, 2019
Genome-scale metabolic model of the rat liver predicts effects of diet restrictionPriyanka Baloni, Vineet Sangar, James T Yurkovich, et al.
International Journal of Cancer|April 8, 2004
Attenuated type II TGF-beta receptor signalling in human malignant oral keratinocytes induces a less differentiated and more aggressive phenotype that is associated with metastatic disseminationSuzy P Huntley, Maria Davies, John B Matthews, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|March 23, 2021
Primary transoral robotic surgery +/- adjuvant therapy for oropharyngeal squamous cell carcinoma-A large observational single-centre series from the United KingdomJames O'Hara, Laura Warner, Hannah Fox, et al.
The Lancet. Oncology|September 30, 2021
Guidelines for cellular and molecular pathology content in clinical trial protocols: the SPIRIT-Path extensionTimothy J Kendall, Max Robinson, Daniel J Brierley, et al.
Oncogene|March 16, 2002
TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrestIan C Paterson, Maria Davies, Andrea Stone, et al.
Pageof 12

Showing results (51-60 of 111) with videos related to

Sort By:
Pageof 12
The Journal of Pathology. Clinical Research|February 26, 2021
Recommendations for cellular and molecular pathology input into clinical trials: a systematic review and meta-aggregationShujing Jane Lim, Kurinchi Gurusamy, Daniel O'Connor, et al.
Oral Oncology|November 10, 2018
Concurrent HPV-related oropharyngeal carcinoma in four couplesHans Prakash Sathasivam, Ramya Bhatia, Paula Bradley, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 20, 2016
Changes in Epidermal Growth Factor Receptor Gene Copy Number during Oral CarcinogenesisTimothy Bates, Matthew Kennedy, Ameena Diajil, et al.
Oral Oncology|May 31, 2022
Transoral robotic surgery and neck dissection alone for head and neck squamous cell carcinoma: Influence of resection margins on oncological outcomesLaura Warner, James T O'Hara, Daniel J Lin, et al.
The Journal of Pathology. Clinical Research|May 31, 2022
Assessment of clinical trial protocols for pathology content using the SPIRIT-Path guidelines highlights areas for improvementPeter Robinson, Chris M Bacon, Shujing J Lim, et al.
Scientific Reports|July 10, 2019
Genome-scale metabolic model of the rat liver predicts effects of diet restrictionPriyanka Baloni, Vineet Sangar, James T Yurkovich, et al.
International Journal of Cancer|April 8, 2004
Attenuated type II TGF-beta receptor signalling in human malignant oral keratinocytes induces a less differentiated and more aggressive phenotype that is associated with metastatic disseminationSuzy P Huntley, Maria Davies, John B Matthews, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|March 23, 2021
Primary transoral robotic surgery +/- adjuvant therapy for oropharyngeal squamous cell carcinoma-A large observational single-centre series from the United KingdomJames O'Hara, Laura Warner, Hannah Fox, et al.
The Lancet. Oncology|September 30, 2021
Guidelines for cellular and molecular pathology content in clinical trial protocols: the SPIRIT-Path extensionTimothy J Kendall, Max Robinson, Daniel J Brierley, et al.
Oncogene|March 16, 2002
TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrestIan C Paterson, Maria Davies, Andrea Stone, et al.
Pageof 12